• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4623524)   Today's Articles (362)   Subscriber (49411)
For: Iaconi AI, Zimmerman MA, Kulkarni AS, Balkrishnan R. Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature. Expert Opin Pharmacother 2008;9:163-74. [DOI: 10.1517/14656566.9.2.163] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Number Cited by Other Article(s)
1
Stratégie thérapeutique, avant tout améliorer le vécu de la maladie. ACTUALITES PHARMACEUTIQUES 2009. [DOI: 10.1016/s0515-3700(09)70506-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
2
Benito-León J, Louis ED, Bermejo-Pareja F. Population-based case-control study of morale in Parkinson’s disease. Eur J Neurol 2009;16:330-6. [DOI: 10.1111/j.1468-1331.2008.02428.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
3
On building models of spoken-word recognition: when there is as much to learn from natural "oddities" as artificial normality. ACTA ACUST UNITED AC 2008;70:1235-42. [PMID: 18927006 DOI: 10.3758/pp.70.7.1235] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA